Goldman Sachs expects Nvidia ’beat and raise,’ lifts price target to $240
Privia Health Group Inc. (PRVA) reached a new milestone, with its stock hitting a 52-week high of 26.1 USD. The healthcare provider, currently valued at $3.19 billion, maintains a "GREAT" financial health score according to InvestingPro analysis. This achievement underscores a significant upward trend for the company, as its stock has experienced a remarkable 43.19% increase over the past year. The surge in stock price reflects growing investor confidence and strong performance in the healthcare sector, supported by robust revenue growth of 12.05% in the last twelve months. Based on InvestingPro’s Fair Value analysis, the stock appears slightly overvalued at current levels, with analysts setting price targets ranging from $22 to $35. As Privia Health continues to expand its presence and enhance its services, the company remains well-positioned to capitalize on future growth opportunities. Get deeper insights into PRVA’s growth potential with InvestingPro’s comprehensive Research Report, featuring 12+ additional ProTips and expert analysis available exclusively for subscribers.
In other recent news, Privia Health Group Inc. reported its Q2 2025 earnings, revealing a notable miss on earnings per share (EPS) forecasts while surpassing revenue expectations. The company posted an EPS of $0.02, falling short of the anticipated $0.05, which reflects a 60% negative surprise. However, revenue reached $521.15 million, exceeding the forecast of $467.03 million by 11.59%. Additionally, Privia Health announced its acquisition of Evolent Care Partners for $100 million, with an additional $13 million contingent on future performance. This transaction is expected to be finalized in the fourth quarter of 2025.
Piper Sandler has reiterated an Overweight rating on Privia Health, adjusting the stock price target to $35.00 from $36.00. Meanwhile, JMP Securities maintains its Market Outperform rating and has raised its price target to $30.00 from $29.00. The price target increase follows Privia Health’s announcement that its nine Accountable Care Organizations achieved $233 million in total Medicare Shared Savings Program savings for the 2024 performance year. These recent developments highlight the ongoing strategic moves and financial updates from Privia Health.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.